GlassScriptPhysician profile
Brenda S Wiley
NPI 1801064266
$10,717.52
in general payments reported to CMS, 2019-2025
60 companies · $2,689 in 2025
The $2,689 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,997 · 2022: $2,280 · 2023: $1,907 · 2024: $1,845 · 2025: $2,689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,641 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,640.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $1,020.67 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $960.09 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Senseonics, Incorporated | $800.00 | 2025 | Eversense |
| Novo Nordisk INC | $677.76 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $652.52 | 2021-2025 | Freestyle Libre 3 |
| Nestle Healthcare Nutrition INC. | $602.11 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $482.01 | 2021-2023 | |
| Medtronic, INC. | $467.91 | 2021-2025 | Inpen Smart Insulin Delivery System |
| Astrazeneca Pharmaceuticals LP | $348.27 | 2021-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $334.42 | 2021-2025 | |
| Recordati_rare_diseases_inc. | $315.59 | 2021-2025 | Isturisa, Signifor Lar |
| Xeris Pharmaceuticals, INC. | $282.61 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Amgen INC. | $259.75 | 2021-2025 | Tepezza, Evenity, Repatha |
| Corcept Therapeutics | $252.12 | 2022-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $230.94 | 2022-2025 |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $215.76 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $210.82 | 2022-2025 | Strensiq |
| Radius Health, INC. | $169.46 | 2023-2025 | Tymlos |
| Insulet Corporation | $153.71 | 2021-2023 | Omnipod |
| Mannkind Corporation | $137.87 | 2021-2025 | Afrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $124.79 | 2021-2025 | Gattex |
| Ascensia Diabetes Care US INC. | $124.62 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $122.48 | 2021-2022 | |
| Amryt Pharma Holdings LTD | $113.65 | 2021-2023 | Mycapssa |
| Eusa Pharma (US) LLC | $111.25 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.01 | 2021-2025 | Jardiance |
| Ibsa Pharma INC. | $107.97 | 2022-2025 | Tirosint, Licart, Flector |
| Esperion Therapeutics, INC. | $97.14 | 2021-2022 | |
| Beta Bionics, INC. | $92.39 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Pfizer INC. | $74.89 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $70.79 | 2025 | |
| Dexcom, INC. | $60.99 | 2023 | Dexcom G6 Transmitter |
| Kyowa Kirin, INC. | $58.90 | 2025 | |
| Antares Pharma, INC. | $56.67 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $50.72 | 2023-2024 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $48.56 | 2021-2022 | |
| Zealand Pharma US, INC. | $48.34 | 2021-2022 | |
| Vistapharm, INC. | $47.07 | 2021 | |
| Amneal Pharmaceuticals LLC | $45.73 | 2021-2023 | Unithroid |
| Braintree Laboratories, INC. | $43.06 | 2021-2025 | Suflave, Sutab |
| Ethicon US, LLC | $41.26 | 2021-2023 | Echelon; Endopath, Contour, Stratafix |
| Grt US Holding, INC. | $40.90 | 2022 | |
| Lifescan, INC. | $40.28 | 2023 | |
| Chiesi USA, INC. | $39.48 | 2024-2025 | Mycapssa, Kengreal |
| Sequel Med Tech, LLC | $38.94 | 2025 | Twiist |
| Amarin Pharma, INC. | $38.85 | 2021 | |
| Qol Medical, LLC | $33.06 | 2023 | Sucraid |
| Tolmar, INC. | $31.58 | 2024-2025 | Jatenzo |
| Janssen Biotech, INC. | $30.53 | 2023-2024 | Stelara |
| Aimmune Therapeutics, INC. | $23.52 | 2025 | Zenpep |
| Mallinckrodt Hospital Products INC. | $22.52 | 2021 | |
| Averitas Pharma INC. | $20.85 | 2025 | Qutenza |
| Alvogen INC | $20.01 | 2025 | Teriparatide |
| Madrigal Pharmaceuticals | $19.03 | 2025 | Rezdiffra |
| Intercept Pharmaceuticals, INC. | $18.67 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.49 | 2022 | |
| Tela Bio, INC. | $15.51 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.92 | 2022 | |
| Aroa Biosurgery Incorporated | $14.36 | 2023 | |
| Baudax Bio INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Wiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.